Carregant...
Oral fluoroquinolones and risk of fibromyalgia
The Food and Drug Administration (FDA) has recently included a black box warning on fibromyalgia‐like symptoms with fluoroquinolones (FQs) but no large epidemiologic study is to date available. We undertook a case–control study using a random sample of 9 053 240 subjects obtained from the PharMetric...
Guardat en:
| Publicat a: | Br J Clin Pharmacol |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
John Wiley and Sons Inc.
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6303210/ https://ncbi.nlm.nih.gov/pubmed/30216492 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.13765 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|